K011609 is an FDA 510(k) clearance for the LIVESURE AMPHETAMINE SCREEN TEST. This device is classified as a Enzyme Immunoassay, Amphetamine (Class II - Special Controls, product code DKZ).
Submitted by Pan Probe Biotech, Inc. (San Diego, US). The FDA issued a Cleared decision on June 8, 2001, 14 days after receiving the submission on May 25, 2001.
This device falls under the Toxicology FDA review panel. Regulated under 21 CFR 862.3100.
| 510(k) Number | K011609 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | May 25, 2001 |
| Decision Date | June 08, 2001 |
| Days to Decision | 14 days |
| Submission Type | Traditional |
| Review Panel | Toxicology (TX) |
| Summary | Summary PDF |
| Product Code | DKZ — Enzyme Immunoassay, Amphetamine |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 862.3100 |